Drawing for MAST ISOPLEX

USPTO serial 79241857

MAST ISOPLEX

Reviewed by CopyMark Law Group

Reg. 7215155Status 700Registered
Filing date
Status date
Registration date
Nov 14, 2023
Examiner
MAKHDOOM, SAIMA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MAST ISOPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JEFFREY A. SMITH

JEFFREY A. SMITH MILLEN, WHITE, ZELANO & BRANIGAN, P.C.2200 CLARENDON BOULEVARDSUITE 1400ARLINGTON, VA 22201

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science; Media for use in laboratories for diagnostic purposes, namely, cell culture media for laboratory use and micro-organism culture media for laboratory use; chemical reagents for molecular biology, other than for medical or veterinary use; Linking agents for scientific use, namely, secondary antibody, conjugates, DNA-DNA, protein-protein, DNA-protein linking agents, other than for medical or veterinary use; reagents for research purposes in kit form for conducting enzyme-linked immunosorbent assays (ELISA); chemical reagents for non-medical purposes in kit form for conducting thermal amplification assays; chemical reagents for non-medical purposes in kit form for thermal amplification or detection of nucleic targets; assay preparations for use in research; Chemical test kits for detecting antibodies for laboratory and research use; parts and fittings for the aforementioned goods; none of the above in relation to proteomics and/or single-cell analysisACTIVE—
005Biological or chemical reagents for use in molecular biology for medical or veterinary use; Biological or chemical reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) for medical or veterinary purposes; chemical reagents for medical or veterinary use in kit form for conducting thermal amplification assays; chemical reagents for medical or veterinary use in kit form for thermal amplification or detection of nucleic targets; antigens for medical or veterinary research; antibodies for medical or veterinary research; antibodies for medical or veterinary immunodiagnostic purposes; Secondary antibody, conjugates, DNA-DNA, protein-protein, DNA-protein linking agents for medical or veterinary use; Medical or veterinary research tests for detecting antibodies; proteins for medical use in binding antibodies; media for use in medical laboratories for diagnostic purposes, namely, cell culture media for medical laboratory use and micro-organism culture media for medical laboratory use; parts and fittings for the aforementioned goods; none of the above in relation to proteomics and/or single-cell analysisACTIVE—
009Scientific apparatus and instruments for diagnostic purposes, namely, diagnostic apparatus for scientific purposes; Analytical apparatus for indicating and measuring inoculated bacterial cultures, for microorganism identification and for the reading of antibiotic susceptibility tests, namely, software and hardware used in image analysis; Computer programs for use in molecular biology for the reading, analysis and correlation of data and reporting of microorganism identification from samples; Apparatus for carrying-out assays, namely, inoculating pins, inoculum pots, microtiter plates, microbiological culture plates, antibiotic susceptibility testing disc dispensers, inoculating pin holders, inoculum pots, bar code readers, PCs (drive and tablet formats), electronic cables, power adapters, marker assemblies, magnifiers, printers, racks for holding microtiter plates, molecular platform amplification units comprising drive modules, power modules and HMI modules and power cables, LEDs, circuit boards, bar code readers and HMIs in tablet form, desiccant packs, disc dispenser canisters, disc dispenser spares for repair; Scientific diagnostic apparatus and instruments, namely, diagnostic apparatus for scientific purposes; Apparatus for carrying out diagnostic tests, namely, inoculating pins, inoculum pots, microtiter plates, microbiological culture plates, antibiotic susceptibility testing disc dispensers, inoculating pin holders, inoculum pots, bar code readers, PCs (drive and tablet formats), electronic cables, power adapters, marker assemblies, magnifiers, printers, racks for holding microtiter plates, molecular platform amplification units comprising drive modules, power modules and HMI modules and power cables, LEDs, circuit boards, bar code readers and HMIs in tablet form, desiccant packs, disc dispenser canisters, disc dispenser spares for repair; Diagnostic testing apparatus for use in medical or veterinary immunoassay procedures Testing apparatus for diagnostic purposes, namely, inoculating pins, inoculum pots, microtiter plates, microbiological culture plates, antibiotic susceptibility testing disc dispensers, inoculating pin holders, inoculum pots, bar code readers, PCs (drive and tablet formats), electronic cables, power adapters, marker assemblies, magnifiers, printers, racks for holding microtiter plates, molecular platform amplification units comprising drive modules, power modules and HMI modules and power cables, LEDs, circuit boards, bar code readers and HMIs in tablet form, desiccant packs, disc dispenser canisters, disc dispenser spares for repair; parts and fittings for the aforementioned goods; none of the above in relation to proteomics and/or single-cell analysis WEBPAGE URL NACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 14, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 14, 2024FIMPFINAL DISPOSITION PROCESSED—
Feb 14, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 14, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 14, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 11, 2023CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Oct 11, 2023APETASSIGNED TO PETITION STAFF—
Sep 14, 2023ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Sep 7, 2023EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 15, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 7, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 7, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2023GPNXNOTIFICATION PROCESSED BY IB—
Feb 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 15, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 1, 2023EXPTEXPARTE APPEAL TERMINATED—
Feb 1, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 3, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 3, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 3, 2023ALIEASSIGNED TO LIE—
Dec 27, 2022EXPIEX PARTE APPEAL-INSTITUTED—
Dec 27, 2022JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Dec 27, 2022EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Dec 26, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 26, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 26, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 26, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 14, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 13, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 13, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2021RNWLINTERNATIONAL REGISTRATION RENEWED—
Nov 18, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Sep 7, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 25, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 20, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 4, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 4, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 18, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 6, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 6, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Jul 6, 2019CNSLSUSPENSION LETTER WRITTEN—
Jun 27, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2019ALIEASSIGNED TO LIE—
Jun 20, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2019RFNTREFUSAL PROCESSED BY IB—
Dec 29, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 29, 2018RFRRREFUSAL PROCESSED BY MPU—
Dec 18, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2018DOCKASSIGNED TO EXAMINER—
Oct 13, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance